How are PLSE straddle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the PLSE straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 229.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$525.15 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a PLSE straddle?

The breakeven for the PLSE straddle priced on this page is roughly $22.73 and $33.28 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PLSE market-implied 1-standard-deviation expected move is approximately 65.82%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current PLSE implied volatility affect this straddle?

PLSE ATM IV is at 229.60% with IV rank near 40.63%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

PLSE Straddle Strategy

PLSE (Pulse Biosciences, Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NASDAQ.

Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015.

PLSE (Pulse Biosciences, Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $1.97B, a beta of 1.66 versus the broader market, a 52-week range of 12.56-31, average daily share volume of 310K, a public-listing history dating back to 2016, approximately 75 full-time employees. These structural characteristics shape how PLSE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.66 indicates PLSE has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a straddle on PLSE?

A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.

Current PLSE snapshot

As of June 30, 2026, spot at $28.16, ATM IV 229.60%, IV rank 40.63%, expected move 65.82%. The straddle on PLSE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this straddle structure on PLSE specifically: PLSE IV at 229.60% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 65.82% (roughly $18.54 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PLSE expiries trade a higher absolute premium for lower per-day decay. Position sizing on PLSE should anchor to the underlying notional of $28.16 per share and to the trader's directional view on PLSE stock.

PLSE straddle setup

The PLSE straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PLSE near $28.16, the first option leg uses a $28.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PLSE chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PLSE shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$28.00	$2.90
Buy 1	Put	$28.00	$2.38

PLSE straddle risk and reward

Net Premium / Debit: -$527.50
Max Profit (per contract): Unbounded
Max Loss (per contract): -$525.15
Breakeven(s): $22.73, $33.28
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.

PLSE straddle payoff curve

Modeled P&L at expiration across a range of underlying prices for the straddle on PLSE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$2,271.50
$6.24	-77.9%	+$1,648.98
$12.46	-55.8%	+$1,026.45
$18.69	-33.6%	+$403.93
$24.91	-11.5%	-$218.59
$31.14	+10.6%	-$213.89
$37.36	+32.7%	+$408.64
$43.59	+54.8%	+$1,031.16
$49.81	+76.9%	+$1,653.68
$56.04	+99.0%	+$2,276.20

When traders use straddle on PLSE

Straddles on PLSE are pure-volatility plays that profit from large moves in either direction; traders typically buy PLSE straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.

PLSE thesis for this straddle

The market-implied 1-standard-deviation range for PLSE extends from approximately $9.62 on the downside to $46.70 on the upside. A PLSE long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current PLSE IV rank near 40.63% is mid-range against its 1-year distribution, so the IV signal is neutral; the straddle thesis on PLSE should anchor more to the directional view and the expected-move geometry. As a Healthcare name, PLSE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PLSE-specific events.

PLSE straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PLSE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PLSE alongside the broader basket even when PLSE-specific fundamentals are unchanged. Always rebuild the position from current PLSE chain quotes before placing a trade.

Frequently asked questions

What is a straddle on PLSE?: A straddle on PLSE is the straddle strategy applied to PLSE (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With PLSE stock trading near $28.16, the strikes shown on this page are snapped to the nearest listed PLSE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are PLSE straddle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the PLSE straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 229.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$525.15 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a PLSE straddle?: The breakeven for the PLSE straddle priced on this page is roughly $22.73 and $33.28 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PLSE market-implied 1-standard-deviation expected move is approximately 65.82%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a straddle on PLSE?: Straddles on PLSE are pure-volatility plays that profit from large moves in either direction; traders typically buy PLSE straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
How does current PLSE implied volatility affect this straddle?: PLSE ATM IV is at 229.60% with IV rank near 40.63%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.